title: Improvement of paradoxical vocal cord dysfunction with integrated psychiatric care.
abstract: BACKGROUND
  Paradoxical vocal cord dysfunction is associated with a high rate of psychiatric comorbidities, including mood, anxiety, somatoform, and personality disorders, and psychosocial distress.
  
  
  OBJECTIVE
  The authors draw attention to this disorder because delayed diagnosis and misdiagnosis are common and can contribute to excessive morbidity.
  
  
  METHODS
  The authors present a case of paradoxical vocal cord dysfunction.
  
  
  RESULTS
  The condition improved dramatically with integrated psychopharmacologic and psychotherapeutic intervention.
  
  
  CONCLUSIONS
  Integrated medication management and psychotherapy by a single psychiatrist-provider with relevant medical understanding can achieve a better alliance between patient and physician and, thus, improved outcomes.
authors: Dept. of Psychiatry, Univ. of Iowa Hospitals and Clinics, Iowa City, IA, USA. drnicolethurston@gmail.com
authors: Nicole L
authors: NL
authors: Thurston
authors: Jess G
authors: JG
authors: Fiedorowicz
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000523:psychology* / Q000628:therapy*; D001521:Behavior Therapy; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D015897:Comorbidity; D003469:Culture; D003511:Cyclohexanols / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000523:psychology / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D004417:Dyspnea / Q000523:psychology*; D005260:Female; D006801:Humans; D055809:Illness Behavior; D016651:Lithium Carbonate / Q000627:therapeutic use*; D011602:Psychophysiologic Disorders / Q000523:psychology* / Q000628:therapy*; D011613:Psychotherapy; D012064:Relaxation Therapy; D012135:Respiratory Sounds; D012934:Social Isolation; D000069470:Venlafaxine Hydrochloride; D014826:Vocal Cord Paralysis / Q000523:psychology* / Q000628:therapy*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D016651:Lithium Carbonate; D000069470:Venlafaxine Hydrochloride